Tommy Lai

288 Fute Zhong Road
Waigaoqiao, 200131, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Total Synthesis of Pedopeptin C.

Total Synthesis of Pedopeptin C.

Journal: Organic letters

Published: June 13, 2025

Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosis.

Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosis.

Journal: Bioorganic & medicinal chemistry letters

Published: September 26, 2024

GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.

GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.

Journal: Journal of medicinal chemistry

Published: July 12, 2021

Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer.

Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer.

Journal: Bioorganic & medicinal chemistry letters

Published: May 04, 2021

Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα).

Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα).

Journal: Bioorganic & medicinal chemistry letters

Published: October 29, 2019

Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927.

Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927.

Journal: Bioorganic & medicinal chemistry letters

Published: March 20, 2019

Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha.

Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha.

Journal: Bioorganic & medicinal chemistry letters

Published: December 13, 2018

From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.

From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: March 24, 2017

Lead optimization of a pyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies.

Lead optimization of a pyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies.

Journal: Bioorganic & medicinal chemistry letters

Published: May 31, 2016

Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).

Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).

Journal: ACS medicinal chemistry letters

Published: February 19, 2016

Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.

Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.

Journal: Nature chemical biology

Published: August 05, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026